Pediatric ESAP 2023-2024
Image For Activity Cover
2 Courses
Expires on Dec 31, 2025
Member: $250.00
Non-Member: $350.00
In-Training Member: $199.00
Resident Member: $250.00
Resident Non-Member: $250.00
Credit Offered
40 AMA PRA Category 1 Credits
40 ABP-MOC Points
40 Participation Credits
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended

The Pediatric Endocrine Self-Assessment Program is a self-study curriculum aimed at physicians seeking initial certification or recertification in endocrinology, program directors interested in a testing and training instrument, and clinicians simply wanting a self-assessment and a broad review of endocrinology. Pediatric ESAP 2023-2024 consists of 100 brand-new multiple-choice questions in all areas of endocrinology, diabetes, and metabolism. There is extensive discussion of each correct answer and references. For accessibility for international practitioners, SI units are included.

Pediatric ESAP is updated with brand-new questions every other year. 

Learning Options
Assess your clinical knowledge through different learning modes:

  • Learning Mode: This is the "traditional" Pediatric ESAP. Answer 100 questions and receive immediate feedback and view the detail answer rationale. This mode must be completed with a passing score of 70% in order to earn CME and MOC.
  • Mock Exam Mode: Perfect for simulating an exam. Retake this mock exam as often as you like and each time the questions will be re-organized. Feedback will be provided after completion of the exam.
    • Topical Learning Mode: Within Mock Exam Mode, you have the option to create your own exams by choosing the topic(s) to be included

This enduring material is presented online and in print format. The estimated time to complete this activity, including review of material, is 40 hours. Participants must achieve a minimum score of 70% to claim CME credit and MOC points. After initially completing the module(s), if participants do not achieve a minimum score of 70%, they have the option to change their answers and make additional attempts to achieve a passing score. Participants also have the option to clear all answers and start over. Credit is only available on the standard Pediatric ESAP learning mode.

LAST REVIEW DATE: January 2023


ACTIVITY EXPIRATION DATE: December 31, 2025 (date after which this enduring material is no longer certified for AMA PRA Category 1 Credits and ABP Medical Knowledge MOC points)

Pediatric ESAP 2023-2024 is a self-study curriculum aimed at physicians seeking initial certification or recertification in pediatric endocrinology, program directors interested in a testing and training instrument, and clinicians simply wanting a self-assessment and a broad review of pediatric endocrinology.

Upon completion of this educational activity, participants will be able to:

  • Recognize clinical manifestations of pediatric endocrine, growth, and metabolic disorders and select among current options for diagnosis, management, and therapy.
  • Identify risk factors for endocrine and metabolic disorders in pediatric patients and develop strategies for prevention.
  • Evaluate pediatric endocrine and metabolic manifestations of systemic disorders.
  • Use current, evidence-based clinical guidelines and treatment recommendations to guide diagnosis and treatment of pediatric endocrine and metabolic disorders.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 40.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 40 MOC points in the American Board of Pediatric’s (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Liuska M. Pesce, MD, Program Chair (2020-present)
Clinical Professor
Pediatric Thyroid Clinic Director
Stead Family Department of Pediatrics
Division of Pediatric Endocrinology and Diabetes
University of Iowa Carver College of Medicine

Li Chan, MD
Reader in Molecular Endocrinology and Metabolism
Honorary Consultant in Paediatric Endocrinology
Centre for Endocrinology
William Harvey Research Institute

Cem S. Demirci, MD

Pediatric Endocrinology
Director, Type 1 Diabetes Program
Connecticut Children’s Medical Center

Oscar Escobar, MD
Associate Professor
University of Pittsburgh School of Medicine
UPMC Children's Hospital of Pittsburgh

Reema L. Habiby, MD
Associate Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Ann & Robert H. Lurie Children’s Hospital of Chicago

Shana McCormack, MD
Assistant Professor of Pediatrics
Children's Hospital of Philadelphia

Ryan S. Miller, MD

Associate Professor
University of Maryland School of Medicine

Ron Newfield, MD
Clinical Professor
University of California – San Diego
Rady Children’s Hospital San Diego

Siobhan Pittock, MD
Pediatric Endocrinologist
Mayo Clinic

Sripriya Raman, MD

Pediatric Endocrinologist
K S Pediatrics

Christine M. Trapp, MD
Pediatric Endocrinology, Connecticut Children's Medical Center
Associate Fellowship Director, Pediatric Endocrinology
Assistant Professor of Pediatrics
University of Connecticut School of Medicine

Halley Wasserman, MD
Assistant Professor
Cincinnati Children's Hospital Medical Center

Ari Wassner, MD
Medical Director, Thyroid Center
Director, Endocrinology Fellowship Training Program
Associate Professor of Pediatrics
Boston Children's Hospital
Harvard Medical School

Abbie L. Young, MS, CGC, ELS(D)
Medical Editor

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s P-ESAP Faculty Working Group.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The following faculty reported relevant financial relationship(s): Li Chan, MD, is an advisory board member of OMass Therapeutics and Great Ormond Street Hospital Children’s Charity Research. Oscar Escobar, MD, is a board member of the Human Growth Foundation. He is a primary
investigator in industry-supported multicentric study for Pfizer, OPKO, and Novo Nordisk. Shana McCormack, MD, is an NIH grantee and grant reviewer. She is a grantee of the Doris Duke Charitable Foundation and the Friedreich Ataxia Research Alliance. She is a consultant for Rhythm Pharmaceuticals and Reata Pharmaceuticals. Ryan S. Miller, MD, is an NIH grantee. Ron Newfield, MD, is a principal investigator for Spruce and Neurocrine for new medications; a consultant for Spruce; a consultant and member of the Independent Safety Committee for Ascendis; a principal investigator for Merck; and a principal investigator for Zealand for dasiglucagon. Ari Wassner, MD, is a topic peer reviewer for UpToDate (thyroid).

The following committee members reported no relevant financial relationships: 
Cem S. Demirci, MD; Reema L. Habiby, MD; Liuska M. Pesce, MD; Siobhan Pittock, MD; Sripriya Raman, MD; Christine M. Trapp, MD; Halley Wasserman, MD.

The medical editor for this program, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

This activity is not supported by educational grant(s) or other funds from any commercial supporter.

     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Android App Download IOS App Download Powered By